This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Apr;13(4):333-4.

doi: 10.1016/S1470-2045(11)70345-X. Epub 2012 Jan 20.

Aromatase inhibitors and musculoskeletal adverse events

Pedro E R Liedke¹, Paul E Goss

Affiliations

PMID: 22265696
DOI: 10.1016/S1470-2045(11)70345-X

Comment

Aromatase inhibitors and musculoskeletal adverse events

Pedro E R Liedke et al. Lancet Oncol. 2012 Apr.

. 2012 Apr;13(4):333-4.

doi: 10.1016/S1470-2045(11)70345-X. Epub 2012 Jan 20.

Authors

Pedro E R Liedke¹, Paul E Goss

Affiliation

¹ Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

PMID: 22265696
DOI: 10.1016/S1470-2045(11)70345-X

No abstract available

PubMed Disclaimer

Comment on

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.
Mieog JS, Morden JP, Bliss JM, Coombes RC, van de Velde CJ; IES Steering Committee. Mieog JS, et al. Lancet Oncol. 2012 Apr;13(4):420-32. doi: 10.1016/S1470-2045(11)70328-X. Epub 2012 Jan 20. Lancet Oncol. 2012. PMID: 22265698 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information